临床外科杂志 ›› 2026, Vol. 34 ›› Issue (4): 407-411.doi: 10.3969/j.issn.1005-6483.20250734

• 论著 • 上一篇    下一篇

肺腺癌气腔播散对肺叶切除术与亚肺叶切除术选择及术后生存转归的影响

徐跻京 李家轩 曹荣华 黄永高   

  1. 225300江苏泰州,泰州市中医院胸外科
  • 收稿日期:2025-07-17 出版日期:2026-06-08 发布日期:2026-06-08
  • 通讯作者: 黄永高,Email:Wsying0202@163.com

Effect of spread through air spaces (STAS) of lung adenocarcinoma on the selection of lobectomy and sublobar resection and postoperative survival outcomes

XU Jijing,LI Jiaxuan,CAO Ronghua,HUANG Yonggao   

  1. Department of Thoracic Surgery,Taizhou Traditional Chinese Medicine Hospital,Jiangsu,Taizhou 225300,China
  • Received:2025-07-17 Online:2026-06-08 Published:2026-06-08

摘要: 目的 探讨肺腺癌气腔播散(STAS)对肺叶切除术与亚肺叶切除术选择及术后生存转归的影响。方法 2018年10月~2022年10月收治的肺腺癌病人196例,根据STAS诊断标准分为STAS阳性组(121例)和STAS阴性组(75例)。收集病人的临床资料、手术方式及随访数据,比较两组病人的临床特征、术式选择和生存结局,比较不同手术方式下STAS状态对预后的影响。结果 与STAS阴性组比较,STAS阳性组病人呈现更大的肿瘤直径、更高的血管、胸膜、神经周围及淋巴管浸润和肿瘤坏死比例,病理分期更高,且肺叶切除术比例更高,差异有统计学意义(P<0.05)。多因素Logistic回归分析显示,STAS状态、肿瘤最大径、血管浸润、淋巴管浸润及病理分期是影响肺腺癌病人术式选择(肺叶切除vs亚肺叶切除)的独立相关因素(P<0.05)。STAS阳性组复发率和死亡率分别为40.50%(49/121)和16.53%(20/121),均显著高于STAS阴性组的14.67%(11/75)和5.33%(4/75),差异有统计学意义(P<0.05)。在STAS阳性组中,亚肺叶切除术病人的复发率及死亡率显著高于肺叶切除术,差异有统计学意义(P<0.05);在STAS阴性组中,两种术式间复发率和死亡率比较差异无统计学意义(P>0.05)。结论 STAS阴性病人,选择肺叶切除与亚肺叶切除术的预后无差异;而STAS阳性病人,选择肺叶切除术的预后优于亚肺叶切除术。

关键词: 肺腺癌, 气腔播散, 肺叶切除术, 亚肺叶切除术, 预后

Abstract: Objective To investigate the effect of spread through air spaces (STAS) of lung adenocarcinoma on the selection of lobectomy and sublobar resection and postoperative survival outcomes.Methods A retrospective analysis was performed on 196 patients with lung adenocarcinoma admitted to our hospital from October 2018 to October 2022.According to the STAS diagnostic criteria,they were divided into a STAS-positive group (121 cases) and a STAS-negative group (75 cases).The clinical data,surgical methods,and follow-up data of the patients were collected,and the clinical characteristics,surgical selection,and survival outcomes of the two groups were compared.The effect of STAS status on prognosis under different surgical methods was further compared.Results Compared with the STAS-negative group,patients in the STAS-positive group presented with larger tumor diameters,higher rates of vascular,pleural,perineural,and lymphovascular infiltration and tumor necrosis,higher pathological stages,and a higher rate of lobectomy (P<0.05).Multivariate Logistic regression analysis showed that STAS status,maximum tumor diameter,vascular invasion,lymphovascular invasion,and pathological stage were independent factors affecting the surgical procedure selection (lobectomy vs sublobar resection) in patients with lung adenocarcinoma (P<0.05).The recurrence rate and mortality rate in the STAS-positive group were 40.50% (49/121) and 16.53% (20/121),respectively,which were significantly higher than those in the STAS-negative group (14.67% (11/75) and 5.33% (4/75)) (P<0.05).In the STAS-positive group,the recurrence rate and mortality rate of patients undergoing sublobar resection were significantly higher than those undergoing lobectomy (both P<0.05);while in the STAS-negative group,there was no statistically significant difference in recurrence rate and mortality between the two surgical procedures (P>0.05).Conclusion For the STAS-negative patients,there is no difference in prognosis between lobectomy and sublobar resection;however,for the STAS-positive patients,lobectomy offers a better prognosis than sublobar resection.

Key words: lung adenocarcinoma, spread through air spaces, lobectomy, sublobar resection, prognosis

[1] 路敏 杨静 孙婧婧 张琳 左明明. 术中低体温对老年胸椎旁神经阻滞麻醉下胸腔镜肺叶切除术后病人早期肺部并发症的影响[J]. 临床外科杂志, 2026, 34(4): 462-466.
[2] 赵庆楠 何代玉 孙笑尘 金丽军. 甲状腺激素应答蛋白Spot 14、尿激酶型纤溶酶原激活物、E26转录因子变异体4与甲状腺乳头状癌颈部淋巴结转移的相关性及预后评估价值[J]. 临床外科杂志, 2026, 34(3): 272-276.
[3] 夏海水 房晓芳 王伟 马上. 血清单酰基甘油酯酶、甘油三磷酸脱氢酶1和人循环前胃泌素表达水平与乳腺癌病人分子分型及预后的关系[J]. 临床外科杂志, 2026, 34(3): 281-285.
[4] 王海 徐幸幸 段文涛 彭勇. 术前血淋巴细胞计数与C反应蛋白的比值、叉头盒蛋白A1对原发性肝癌肝动脉化疗栓塞术术后预后的预测价值分析[J]. 临床外科杂志, 2026, 34(3): 290-295.
[5] 韦树健 秦琦 侯国强 范青禄 聂志浩 胡海丰 刘高利 谢颂平. 皮内缝合联合改良置管在肺癌单孔腔镜肺叶切除术中的应用及其对切口愈合的影响[J]. 临床外科杂志, 2026, 34(2): 135-138.
[6] 吴梓政 魏元君 郑杰 韩猛. 趋化因子配体9 mRNA在三阴性乳腺癌中的表达及临床意义[J]. 临床外科杂志, 2026, 34(2): 150-155.
[7] 柯贤鹏 王立松 王鹏斌 王琦 陈星晨. 改良股骨髓内钉与动力髋螺钉治疗股骨转子间骨折的临床疗效观察[J]. 临床外科杂志, 2026, 34(2): 205-208.
[8] 赵攀, 张明, 吴健, 肖刘敏, 程济明, 张子龙. 胃癌组织中血小板反应蛋白2和富含半胱氨酸的酸性分泌蛋白的表达与胃癌病人氧化应激、临床病理特征和预后的关系[J]. 临床外科杂志, 2026, 34(1): 69-73.
[9] 杨永林, 闫申辉, 孙晓冰. 肠气囊肿病一例[J]. 临床外科杂志, 2026, 34(1): 114-115.
[10] 杜宁彬 王居正 郭玲 胡艳正. 长链非编码RNA XIST和微小RNA-186-5p在非小细胞肺癌组织中的表达及其与病理特征的相关性[J]. 临床外科杂志, 2025, 33(9): 953-957.
[11] 杨谦 张军 马玉泉 李志国 毛诏旭. 肺腺癌组织lncRNA MALAT1、miR-181a-5p表达与JAK2/STAT3信号通路、临床病理特征及预后的关系[J]. 临床外科杂志, 2025, 33(9): 958-963.
[12] 方丽 田云霄 高庆利 牛广旭. 细胞周期蛋白B2、细胞周期蛋白E表达与肝癌病人临床病理特征及5年生存率的关系分析[J]. 临床外科杂志, 2025, 33(9): 981-984.
[13] 孙磊 杨玉亭 李朝辉. 胫骨平台伴髁间棘骨折病人术后关节功能恢复的影响因素及其预测效能研究[J]. 临床外科杂志, 2025, 33(9): 992-996.
[14] 黄志刚 张兴伟 张宇 邹青旭. N-乙酰转移酶10、丝氨酸羟甲基转移酶 2、YTHN6-甲基腺苷RNA结合蛋白1在肺癌组织中的表达及与临床病理特征、预后的相关性[J]. 临床外科杂志, 2025, 33(8): 827-831.
[15] 汪俊 吕瑕智 陶玉 胡传朋. 血清微小核糖核酸-335-5p、内皮细胞特异性分子-1对食管癌病人的早期诊断及预后评估价值[J]. 临床外科杂志, 2025, 33(8): 836-840.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!